Immunovant, Inc. (IMVT)
Nasdaq: IMVT · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Period ending | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
| Report filed | May 20, 2026 | May 29, 2025 | May 29, 2024 | May 22, 2023 | Jun 8, 2022 | Jun 1, 2021 | Jun 29, 2020 | · |
| For lenders | ||||||||
| Net interest income | · | · | 24,948 | 7,578 | 0 | · | · | · |
| Research and development | 456,660 | 360,917 | 212,928 | 160,257 | 101,808 | 68,604 | 47,927 | 25,733 |
| General and administrative | 76,242 | 77,235 | 57,281 | 48,019 | 54,225 | 39,513 | 18,151 | 2,692 |
| Total operating expenses | 532,902 | 438,152 | 282,709 | 218,276 | 156,033 | 108,117 | 66,078 | 28,425 |
| Interest expense | · | · | · | · | · | 0 | 625 | · |
| Interest income (expense), net | 25,330 | 24,732 | 24,948 | 7,578 | · | · | · | · |
| Other income (expense), net | 2,181 | 471 | -1,008 | -253 | -781 | 328 | 412 | -155 |
| Income before income taxes | -505,391 | -412,949 | -258,769 | -210,951 | -156,814 | -107,789 | -66,291 | -28,580 |
| Income tax expense | 215 | 891 | 567 | 9 | -84 | -358 | 97 | 19 |
| Net income | -505,606 | -413,840 | -259,336 | -210,960 | -156,730 | -107,431 | -66,388 | -28,599 |
| Earnings per share, basic | -2.77 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | · | · |
| Earnings per share, diluted | -2.77 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -1.22 | -1.54 | -1.29 |
| Weighted average shares, basic | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
| Weighted average shares, diluted | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 87,756,513 | 43,199,191 | 22,170,862 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted